Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix

Ulrich Knigge; Carsten Palnaes Hansen

Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix

Translated title of the contribution: [Appendiceal carcinoid tumors and goblet cell carcinoids]

Ulrich Knigge, Carsten Palnaes Hansen

3 Citations (Scopus)

Abstract

Appendicial carcinoid tumors (CAT) and goblet cell carcinoids (GCCAT) are rare. Most are asymptomatic and found after appendectomy. Metastases to regional nodes are seen in 10% of CATs larger than two cm. Ovarial or peritoneal metastases are seen in 20% of all GCCATs. Further surgical treatments are shown in Tables. Non-resectable CAT are treated with interferon-alpha, somatostatin analogs or radionuclids. Non-resectable GCCATs are treated like colo-rectal cancer. Patients with CAT larger than two cm, involvement of mesoappendix or metastases and all GCCAT should be followed life-long.

Translated title of the contribution	[Appendiceal carcinoid tumors and goblet cell carcinoids]
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	172
Issue number	22
Pages (from-to)	1678-81
Number of pages	4
ISSN	0041-5782
Publication status	Published - 31 May 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{bb39c34b080046ea9d16521f9f491468,

title = "Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix",

abstract = "Appendicial carcinoid tumors (CAT) and goblet cell carcinoids (GCCAT) are rare. Most are asymptomatic and found after appendectomy. Metastases to regional nodes are seen in 10% of CATs larger than two cm. Ovarial or peritoneal metastases are seen in 20% of all GCCATs. Further surgical treatments are shown in Tables. Non-resectable CAT are treated with interferon-alpha, somatostatin analogs or radionuclids. Non-resectable GCCATs are treated like colo-rectal cancer. Patients with CAT larger than two cm, involvement of mesoappendix or metastases and all GCCAT should be followed life-long.",

author = "Ulrich Knigge and Hansen, {Carsten Palnaes}",

year = "2010",

month = may,

day = "31",

language = "Dansk",

volume = "172",

pages = "1678--81",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "22",

}

TY - JOUR

T1 - Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix

AU - Knigge, Ulrich

AU - Hansen, Carsten Palnaes

PY - 2010/5/31

Y1 - 2010/5/31

N2 - Appendicial carcinoid tumors (CAT) and goblet cell carcinoids (GCCAT) are rare. Most are asymptomatic and found after appendectomy. Metastases to regional nodes are seen in 10% of CATs larger than two cm. Ovarial or peritoneal metastases are seen in 20% of all GCCATs. Further surgical treatments are shown in Tables. Non-resectable CAT are treated with interferon-alpha, somatostatin analogs or radionuclids. Non-resectable GCCATs are treated like colo-rectal cancer. Patients with CAT larger than two cm, involvement of mesoappendix or metastases and all GCCAT should be followed life-long.

AB - Appendicial carcinoid tumors (CAT) and goblet cell carcinoids (GCCAT) are rare. Most are asymptomatic and found after appendectomy. Metastases to regional nodes are seen in 10% of CATs larger than two cm. Ovarial or peritoneal metastases are seen in 20% of all GCCATs. Further surgical treatments are shown in Tables. Non-resectable CAT are treated with interferon-alpha, somatostatin analogs or radionuclids. Non-resectable GCCATs are treated like colo-rectal cancer. Patients with CAT larger than two cm, involvement of mesoappendix or metastases and all GCCAT should be followed life-long.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 1678

EP - 1681

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 22

ER -

Karcinoide tumorer og gobletcelle-karcinoide tumorer i appendix

Abstract

UN SDGs

Fingerprint

Cite this